
株式会社Veritas In Silico
130A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 品川区西五反田一丁目11番1号
- Website:
- https://www.veritasinsilico.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
株式会社Veritas In Silico is a pioneering Japanese biotechnology company focused on the development of innovative low molecular weight pharmaceuticals targeting mRNA and nucleic acids. Established in Tokyo, the company is committed to advancing drug discovery through cutting-edge research and strategic collaborations with leading pharmaceutical firms such as Takeda and Mitsubishi Gas Chemical. Veritas In Silico leverages its proprietary technologies to create novel therapeutic solutions, aiming to address unmet medical needs in various diseases. The company has recently gained attention for its growth potential and is actively engaged in partnerships to enhance its drug development pipeline. With a vision for a healthier future, Veritas In Silico aspires to transform the landscape of modern medicine.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-03-28 05:18 |
Inside Information Statement
臨時報告書
|
Japanese | 27.1 KB | |
2025-03-28 02:47 |
Internal Control over Financial Reporting
内部統制報告書-第9期(2024/01/01-2024/12/31)
|
Japanese | 22.5 KB | |
2025-03-28 02:47 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
2025-03-28 02:46 |
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
|
Japanese | 3.1 MB | |
2024-08-14 08:00 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
2024-08-14 08:00 |
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
|
Japanese | 171.1 KB | |
2024-05-15 09:55 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
2024-05-15 08:00 |
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
|
Japanese | 146.8 KB | |
2024-03-15 07:01 |
Inside Information Statement
臨時報告書
|
Japanese | 23.2 KB | |
2024-03-15 07:00 |
Annual Report
有価証券報告書-第8期(2023/01/01-2023/12/31)
|
Japanese | 3.1 MB | |
2024-02-08 01:05 |
Inside Information Statement
臨時報告書
|
Japanese | 21.1 KB | |
2024-01-31 07:00 |
Regulatory News Service
訂正有価証券届出書(新規公開時)
|
Japanese | 2.4 MB | |
2024-01-23 07:00 |
Regulatory News Service
訂正有価証券届出書(新規公開時)
|
Japanese | 2.4 MB | |
2024-01-05 07:00 |
Prospectus
有価証券届出書(新規公開時)
|
Japanese | 5.0 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP | |
ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
![]() |
Astellas Pharma Inc. | Japan | 4503 | |
![]() |
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
![]() |
Biofarm S.A. | Romania | BIO | |
![]() |
Biogened Spolka Akcyjna | Poland | BGD |